Systematic Reviews
Copyright ©The Author(s) 2016.
World J Radiol. Oct 28, 2016; 8(10): 829-845
Published online Oct 28, 2016. doi: 10.4329/wjr.v8.i10.829
Figure 1
Full Size Figure Download Figure
Figure 1 Maximum intensity projection image of an positron emission tomography with 18F-Fluorodehoxiglucose examination shows diffuse and intense radiopharmaceutical uptake in the large bowel. Reprinted with permission of Springer Verlag from Cistaro et al.
  • Citation: Caobelli F, Evangelista L, Quartuccio N, Familiari D, Altini C, Castello A, Cucinotta M, Di Dato R, Ferrari C, Kokomani A, Laghai I, Laudicella R, Migliari S, Orsini F, Pignata SA, Popescu C, Puta E, Ricci M, Seghezzi S, Sindoni A, Sollini M, Sturiale L, Svyridenka A, Vergura V, Alongi P, Young AIMN Working Group. Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art. World J Radiol 2016; 8(10): 829-845
  • URL: https://www.wjgnet.com/1949-8470/full/v8/i10/829.htm
  • DOI: https://dx.doi.org/10.4329/wjr.v8.i10.829